The present study seeks to examine the implementation process of culturally tailoring screening and brief intervention for both chronic pain and opioid misuse/opioid use disorder in three American Indian and Alaska Native (AI/AN) serving clinics. The investigators also will assess staff perspectives on this implementation as well as a survey to understand clients at these sites who have chronic pain and opioid misuse/opioid use disorder.
The present study seeks to examine the implementation process of culturally tailoring screening and brief intervention for both chronic pain and opioid misuse/opioid use disorder in three American Indian and Alaska Native (AI/AN) serving clinics. The investigators also will assess staff perspectives on this implementation as well as a survey to understand clients at these sites who have chronic pain and opioid misuse/opioid use disorder.
Opioid and Pain Treatment in Indigenous Communities (OPTIC) Trial
-
Clinic Site A (blinded pending tribal approval), Arcata, California, United States, 95521
Clinic Site C (blinded pending tribal approval), Minneapolis, Minnesota, United States, 55404
Clinic Site B (blinded pending tribal approval), Toppenish, Washington, United States, 98948
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
For general information about clinical research, read Learn About Studies.
18 Years to
ALL
No
University of New Mexico,
Matthew R Pearson, PhD, PRINCIPAL_INVESTIGATOR, University of New Mexico
2028-07